Leaders of Drug Co. Hurt Stock With Lies, Suit Says
Current and former directors of biopharmaceutical company Spero were hit with accusations in a Delaware federal court Wednesday that they caused the company to make false statements about the likelihood of one...To view the full article, register now.
Already a subscriber? Click here to view full article